# Review of the scenario update

## Overall assessment

The regenerated scenario outputs are internally consistent with the key results in claude.md. The main scenario table and the generated report include 95% uncertainty intervals (UIs), and the figures are documented as showing posterior medians only. The updated claude.md now reports that the repository test suite passed, but it still states an 80% incidence target; it has not incorporated the confirmed 90% threshold.

Two reporting issues remain before treating the repository's conclusions as final:

1. The analysis still uses an 80% incidence reduction threshold, but the governing threshold is now 90%.
2. The root-level 结论.md still contains the previous single-parameter-point results and does not include 95% UIs. Some explanatory text in the generated output/scenarios_2026/README.md also uses explicitly labelled old single-point figures.

I did not modify the model or scenario result files, and I did not rerun the scenario analysis or tests.

## 1. Consistency with the generated scenario results

I checked claude.md against output/scenarios_2026/scenario_2030_summary.csv and the scenario README. The key statements match the generated files:

- There are 17 scenarios: 15 finite capacity and allocation combinations, J-only, and the unlimited-capacity reference. The finite capacities are 600, 1,000, 2,000, 5,000, and 8,000 per year, with F allocations of 25%, 50%, and 75%.
- The generated endpoint table contains 2,000 posterior draws per scenario.
- Under the generated files' median-based 80% incidence and 65% mortality criteria, three finite scenarios pass both targets: 5,000/year with F at 25%, and 8,000/year with F at 25% or 50%. The no-cap reference also passes; J-only and the other 12 finite scenarios fail. These are not yet classifications under the now-governing 90% incidence threshold.
- The 5,000/year, F 25% scenario has median mortality reduction 65.1% (95% UI 63.7%–66.4%) and a 55.95% joint pass probability. Calling it a median PASS but not a robust result is accurate.
- The 8,000/year scenarios have joint pass probabilities of 100% for F 25% and 91.9% for F 50%; the no-cap reference is 100%. These match the report, subject to its rounding.

The new posterior medians are broadly consistent with the earlier single-point summary, with small expected differences from aggregating posterior draws. For example, J-only incidence reduction is now 75.9% rather than the earlier 76.0%; the 5,000/F 25% total discounted cost is S$62.18m rather than S$62.03m. These are not contradictions when the estimand has changed from one parameter vector to a posterior summary.

## 2. Model assumptions and implementation

I found no clear violation of the core model contract in the reviewed analysis code:

- It uses the existing 480 compartments (D/J/F/X, four liver stages, six age groups, and u/a/c/t/r states). Transmission remains in D and F; J and X have no infection force. Recovered people can be reinfected in active strata.
- Each posterior draw gets its own 2015 equilibrium check and common 2016–2025 history, with J treatment from 2019. All policy scenarios branch from that draw's same 2026 state. F/X policy treatment starts in 2026.
- F/X annual screening and treatment quotas are calculated once from the year-start state. The denominator excludes people already in treatment, and only chronic c contributes to treatment capacity. The code keeps the documented aggregate-screening approximation: it does not track individual screening history or a diagnosed waiting queue, and a person may contribute to screening estimates in multiple years.
- The C++ capacity path stops new c→t starts at each stratum's annual quota while allowing existing t courses to continue. The annual simulation call resets the counter for the next year. Treatment starts are labelled as expected course starts, not unique people.
- Costs are calculated for 2026–2030, with annual costs discounted to 2026. The posterior intervals cover model parameter uncertainty only; uptake, linkage, capacity, and price uncertainty are explicitly excluded.

One unit detail is worth preserving: model time is measured in years (dt = 1/365 and treatment duration is specified in years). The script therefore uses -log(1-p) as a per-model-year hazard to produce the configured annual start probability absent competing events. Dividing this value by 365 without also changing the ODE's time unit would make annual treatment initiation far lower than specified.

These checks are a code and output review, not a fresh end-to-end validation. The updated claude.md reports that Rscript scripts/run_tests.R --scope all passed with 6 files, 62 checks, and 0 failures. It also states that these tests do not exercise scripts/scenarios_2026.R, so the scenario-specific calculations and output generation remain outside that test coverage. I have not independently run the suite.

The analysis inputs were reconstructed during the other agent's work: the calibration target file was rebuilt from the NPE observation vector, and the SingStat/CNB inflow file was copied from a sibling checkout. The provenance is noted in data/README.md, and claude.md reports an exact reproduction of the former single-point summary. I did not independently verify the copied inflow file or reproduce that comparison, so this is a provenance check still worth completing, not evidence of a model-contract violation.

## 3. 95% UI reporting

The requested UI reporting is present in the main generated result products:

- output/scenarios_2026/README.md reports medians and 95% UIs for scenario outcomes, costs, and service totals in its summary table and explains that the intervals are the 2.5th–97.5th percentiles across posterior draws.
- scenario_2030_summary.csv includes _lo/_hi fields and formatted 95% UI text. The annual services and treatment summary tables also contain lower and upper interval columns. scenario_results.xlsx includes the endpoint, annual, and treatment tables.
- The figures omit UI bands, as allowed, and are described as showing medians only.

The root-level 结论.md is an exception: it still reports the earlier single-point numbers without UIs. It should not be presented as the current posterior-based conclusion report. The root codex.md has been updated to note the 90% instruction, but still summarizes scenario outputs generated under the old 80% threshold. In addition, the generated README's section explaining low-capacity starts uses old single-point 2030 figures; it labels them as old, but the section should be recalculated or made clearly historical to avoid readers mixing it with the new posterior results.

## 4. Incidence threshold mismatch

Although claude.md has been updated, its threshold statement still says 80% incidence and 65% mortality. The scenario code, output README, and docs/structured_prompt.md also use 80%/65%. The user has confirmed that the governing incidence threshold is now 90%. The checked-in scenario results therefore still use the wrong incidence threshold. Their reported incidence PASS flags, joint status fields, heatmap, target trajectories, and narratives based on the 80% line need to be regenerated or relabelled for 90%.

From the current medians, the finite scenarios that also pass the 65% mortality threshold appear to exceed 90% incidence reduction, so the median-based joint PASS set may remain the same. That does not make the existing target outputs current: individual incidence classifications and posterior pass probabilities must be recomputed using 90%, then verified against the saved scenario draw data or by rerunning the same posterior draws.

## Recommended follow-up

- Apply the confirmed 90% incidence target and regenerate the classifications, report, heatmap, and target trajectories from the same posterior draws; verify the joint status and probability outputs.
- Update 结论.md and the old single-point explanatory paragraph in the generated README so all narrative claims use the current posterior medians and UIs.
- Run the repository test suite after the scenario refactor before relying on the capacity and aggregation code in a final deliverable.
